![William Nichols](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Nichols
Chief Tech/Sci/R&D Officer at
CANDEL THERAPEUTICS, INC.
Net worth: 435 692 $ as of 2026-05-30
Profile
William Garrett Nichols is Chief Medical Officer at Candel Therapeutics, Inc. since 2022.
Formerly, Chief Medical Officer at Istari Oncology, Inc. from 2020 to 2022, Chief Medical Officer at Chimerix, Inc. from 2014 to 2020, Vice President-Clinical Development at GSK Plc from 2008 to 2014, Head-Global Development at ViiV Healthcare Ltd., and Head-Infection Control at Fred Hutchinson Cancer Research Center.
Education includes a doctorate from Duke University and graduate studies at the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 52,493 ( 0.07% ) | 435 692 $ | 2026-05-30 |
William Nichols active positions
| Companies | Position | Start |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-09-11 |
Former positions of William Nichols
| Companies | Position | End |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Chief Tech/Sci/R&D Officer | 2022-03-31 |
| CHIMERIX, INC. | Chief Tech/Sci/R&D Officer | 2020-04-06 |
| GSK PLC | Corporate Officer/Principal | 2014-03-31 |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Corporate Officer/Principal | - |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Training of William Nichols
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology that focused on novel immuno-oncology and immunotherapy products | Health Technology |
- Stock Market
- Insiders
- William Nichols
